Crystal structure and mechanism of a carbon-carbon bond hydrolase

Structure

Volumn 7, Issue 9, 1999, Pages 1023-1033

  Timm, David E ^a,b   Mueller, Heather A ^a   Bhanumoorthy, P ^a   Harp, Joel M ^b   Bunick, Gerard J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Amino acid metabolism; Catalytic triad; Hereditary tyrosinemia; Hydrolase; Metalloenzyme; X ray crystallography

Indexed keywords

FUMARYLACETOACETASE;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOMATION; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS;

EID: 0033200322     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80170-1     Document Type: Article

References (40)

1. 1. Lindblad, B., Lindstedt, S., & Steen, G. (1977). On the enzymic defects in hereditary tyrosinemia. Proc. Natl Acad. Sci. USA 74, 4641-4645.
2. 2. Tanguay, R.M., Jorquera, R., Poudrier, J., & St-Louis, M. (1996). Tyrosine and its catabolites: from disease to cancer. Acta Biochim. Pol. 43, 209-216.
3. 3. Jorquera, R. & Tanguay, R.M. (1997). The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochem. Biophys. Res. Commun. 232, 42-48.
4. 4. Endo, F., et al. & Matsuda, I. (1997). Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. J. Biol. Chem. 272, 24426-24432.
5. 5. Mahuran, D.J., Angus, R.H., Braun, C.V., Sim, S.S., & Schmidt, D.E. (1977). Characterization and substrate specificity of fumarylacetoacetate fumarylhydrolase. Can. J. Biochem. 55, 1-8.
6. 6. Hsiang, H.H., Sim, S.S., Mahuran, D.J. & Schmidt, D.E. (1972). Purification and properties of a diketo acid hydrolase from beef liver. Biochemistry 11, 2098-2102.
7. 7. Nagainis, M.P., Pu, W., Cheng, B., Taylor, K.E. & Schmidt, D.E. (1981). Effects of pH and sulfhydryl specific reagents on 4-fumarylacetoacetate fumarylhydrolase. Biochim. Biophys. Acta 657, 203-211.
8. 8. Lenz H., Wunderwald P., Eggerer H. (1976). Partial purification and some properties of oxalacetase from Aspergillus niger. Eur. J. Biochem. 65, 225-236.
9. 9. Timmis K.N., Steffan R.J., Unterman R. (1994). Designing microorganisms for the treatment of toxic wastes. Annu. Rev. Mirobiol. 48, 525-557.
10. 10. Yang, W., Hendrickson, W.A., Crouch, R.J., & Satow, Y. (1990). Structure of ribonuclease H phased at 2 Å resolution by MAD analysis of the selenomethionyl protein. Science 249, 1398-1405.
11. 11. Orengo, C.A., Michie, A.D., Jones, S., Swindells, M.B. & Thornton, J.M. (1997). CATH-a hierarchic classification of protein domain structures. Structure 5, 1093-1108.
12. 12. Murzin, A.G., Brenner, S.E., Hubbard, T. & Chothia, C. (1995). SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536-540.
13. 13. Holm, L. & Sander C. (1998). Touring protein fold space with Dali/FSSP. Nucleic Acids Res. 26, 316-319.
14. 14. Lu G. A WWW service system for automatic comparison of protein structures. (1996). PDB Newsletter 78, 10-11.
15. 15. Aponte, J.L., Sega, G.A., Withrow, C.M., Carpenter, D.A., Rinchik, E.M. & Johnson, D.K. (1999). Point mutations in the murine Fah gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Proc Natl Acad Sci USA 95, In press.
16. 16. St-Louis, M. & Tanguay, R.M. (1997). Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview. Hum. Mutat. 9, 291-299.
17. 17. Braun C.V. & Schmidt D.E. (1973) Inhibition of fumarylacetoacetate fumarylhydrolase by monovalent anions. Biochemistry 12, 4878-4881.
18. 18. Bild G.S & Morris J.C. (1984). Detection of beta-carbanion formation during kynurenine hydrolysis catalyzed by Pseudomonas marginalsi kynureninase. Arch. Biochem. Biophys. 235, 41-47.
19. 19. Diaz E. & Timmis K.N. (1995). Identification of functional residues in a 2-hydroxymuconic semialdehyde hydrolase. J. Biol. Chem. 270, 6403-6411.
20. 20. Ollis, D.L., et al. & Goldman, A. (1992). The alpha/beta hydrolase fold. Protein Eng. 5, 197-211.
21. 21. Doherty, D.G. (1955). The hydrolysis of carbon-carbon bonds by alpha-chymotrypsin. J. Biol. Chem. 77, 4887-4892.
22. 22. Dodson, G. & Wlodawer, A. (1998). Catalytic triads and their relatives. Trends Biochem. Sci. 23, 347-352.
23. 23. Schrag, J.D., Li, Y.G., Wu, S. & Cygler, M. (1991). Ser-His-Glu triad forms the catalytic site of the lipase from Geotrichum candidum. Nature 351, 761-764.
24. 24. Suck, D. & Oefner, C. (1986). Structure of DNase I at 2.0 Å resolution suggests a mechanism for binding to and cutting DNA. Science 321, 620-625.
25. 2. Nature 289, 604-606.
26. 2 complexed with a substrate-derived inhibitor. Nature 347, 689-691.
27. 2 in a complex with a transition-state analogue. Science 250, 1560-1563.
28. 2 in a complex with a transition-state analogue. Science 250, 1563-1566.
29. 29. Essen, L.O., Perisic, O., Katan, M., Wu, Y., Roberts, M.F. & Williams, R.L. (1997). Structural mapping of the catalytic mechanism for a mammalian phosphoinositide-specific phospholipase C. Biochemistry 36, 1704-1718.
30. 30. Bone, R., Frank, L., Springer, J.P. & Atack, J.R. (1994). Structural studies of metal binding by inositol monphosphatase: evidence for two-metal ion catalysis. Biochemistry 33, 9468-9476.
31. 31. Overturf, K., al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.N., Finegold, M., & Grompe M. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 12, 266-273.
32. 32. Klebig, M.L., Russell, L.B. & Rinchik, E.M. (1992). Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus. Proc. Natl Acad. Sci. USA 89, 1363-1367.
33. 33. Harp, J.M., Timm, D.E. & Bunick, G.J. (1998). Macromolecular crystal annealing: overcoming increased mosaicity associated with cryocrystallography. Acta Crystallogr. D 54, 622-628.
34. 34. Otwinowski Z. & Minor W. (1997). Processing of X-ray diffraction data collected in oscillation data reduction mode. Methods Enzymol. 276, 307-326.
35. 35. Terwilliger T.C. (1997). Multiwavelength anomalous diffraction phasing of macromolecular structures: analysis of MAD data as single isomorphous replacement with anomalous scattering data using the MADMRG Program. Methods Enzymol. 276, 530-537.
36. 36. CCP4. (1979). The SERC (UK) Collaborative Computing Project No. 4, A suite of programs for protein crystallography, distributed from Daresbury Laboratory, Warrington WA4 4AD, UK.
37. 37. Ramakrishnan V. & Biou V. (1997). Treatment of multiwavelength anomalous diffraction data as a special case of multiple isomorphous replacement. Methods Enzymol. 276, 538-557.
38. 38. Jones TA, Zou JY, Cowan SW, & Kjeldgaard (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
39. 39. Brünger, A.T. (1992). X-PLOR version 3.1. A system for X-ray crystallography and NMR. New Haven: Yale University Press.
40. 40. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.